ARCHIVES

Kadcyla Extends Median PFS In Open-Label Phase III Trial

This article is from The Cancer Letter archive.

Vol. 36 No. 10 | October 25, 2013

Download PDF Visit The Full Archive

Related Articles

RFA Available

January 15, 1999

DCT Advisors OK 4 Contract Concepts In Therapeutics

June 28, 1991

In Brief: Whittaker Corp, Trying To Hire NCI Director; Environmental Carcinogenesis On NCAB Agenda

February 13, 1976

PR Firm Hired By American Cancer Society Also Represents “Team KOOL Green”.

January 28, 2000

Deparle Leaves HCFA; Speyer Promoted At NYU Center.

September 15, 2000

Faulding, NaPro In Agreement For Marketing Paclitaxel.

March 30, 2001